The DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma
Open accessAbstract
The pursuit of matrix metalloproteinase (MMP) inhibitors began in earnest over three decades ago. Initial clinical trials were disappointing, resulting in a negative view of MMPs as therapeutic targets. As a better understanding of MMP biology and inhibitor pharmacokinetic properties emerged, it became clear that initial MMP inhibitor clinical trials were held prematurely. Further complicating matters were problematic conclusions drawn from animal model studies. The most recent generation of MMP inhibitors have desirable selectivities and improved pharmacokinetics, resulting in improved toxicity profiles. Application of selective MMP inhibitors led to the conclusion that MMP-2, MMP-9, MMP-13, and MT1-MMP are not involved in musculoskeletal syndrome, a common side effect observed with broad spectrum MMP inhibitors. Specific activities within a single MMP can now be inhibited. Better definition of the roles of MMPs in immunological responses and inflammation will help inform clinic trials, and multiple studies indicate that modulating MMP activity can improve immunotherapy. There is a U.S. Food and Drug Administration (FDA)-approved MMP inhibitor for periodontal disease, and several MMP inhibitors are in clinic trials, targeting a variety of maladies including gastric cancer, diabetic foot ulcers, and multiple sclerosis. It is clearly time to move on from the dogma of viewing MMP inhibition as intractable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Matrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,750
Strategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Gehron Robey, P., Poole, A. R., Pidoux, I., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80064-1 · Cited by 1,298
Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1821 · Cited by 1,214
Metalloproteinases and Wound Healing
Caley, M. P., Martins, V. L. C., & O'Toole, E. A. (2015) · Advances in Wound Care · doi:10.1089/wound.2014.0581 · Cited by 986
Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors
Whittaker, M., Floyd, C. D., Brown, P., & Gearing, A. J. H. (1999) · Chemical Reviews · doi:10.1021/cr9804543 · Cited by 982
Is there new hope for therapeutic matrix metalloproteinase inhibition?
Vandenbroucke, R. E., & Libert, C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4390 · Cited by 832
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases
Hu, J., Van den Steen, P. E., Sang, Q.-X. A., & Opdenakker, G. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2308 · Cited by 795
Vandooren, J., Van den Steen, P. E., & Opdenakker, G. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.770819 · Cited by 766
Progress in matrix metalloproteinase research
MURPHY, G., & NAGASE, H. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.05.002 · Cited by 759
Romanic, A. M., White, R. F., Arleth, A. J., Ohlstein, E. H., & Barone, F. C. (1998) · Stroke · doi:10.1161/01.str.29.5.1020 · Cited by 739
Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers
Rempe, R. G., Hartz, A. M., & Bauer, B. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16655551 · Cited by 721
Murine Caspase-11, an ICE-Interacting Protease, Is Essential for the Activation of ICE
Wang, S., Miura, M., Jung, Y.-K., Zhu, H., Li, E., & Yuan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)80943-5 · Cited by 698
Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non-Antimicrobial Mechanisms
Golub, L. M., Lee, H.-M., Ryan, M. E., Giannobile, W. V., Payne, J., & Sorsa, T. (1998) · Advances in Dental Research · doi:10.1177/08959374980120010501 · Cited by 687
Van den Steen, P. E., Proost, P., Wuyts, A., Van Damme, J., & Opdenakker, G. (2000) · Blood · doi:10.1182/blood.v96.8.2673 · Cited by 680
Zhou, Z., Apte, S. S., Soininen, R., Cao, R., Baaklini, G. Y., Rauser, R. W., Wang, J., Cao, Y., & Tryggvason, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060037197 · Cited by 666
Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes
Winer, A., Adams, S., & Mignatti, P. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0646 · Cited by 651
Ardi, V. C., Kupriyanova, T. A., Deryugina, E. I., & Quigley, J. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706438104 · Cited by 602
Bramhall, S. R., Schulz, J., Nemunaitis, J., Brown, P. D., Baillet, M., & Buckels, J. A. C. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600446 · Cited by 557
Metalloproteinases and their natural inhibitors in inflammation and immunity
Khokha, R., Murthy, A., & Weiss, A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3499 · Cited by 552
Candelario-Jalil, E., Yang, Y., & Rosenberg, G. A. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.025 · Cited by 527
Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator
Wang, X., Lee, S.-R., Arai, K., Lee, S.-R., Tsuji, K., Rebeck, G. W., & Lo, E. H. (2003) · Nature Medicine · doi:10.1038/nm926 · Cited by 460
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity
Ferrari de Andrade, L., Tay, R. E., Pan, D., Luoma, A. M., Ito, Y., Badrinath, S., Tsoucas, D., Franz, B., May, K. F., Harvey, C. J., et al. (2018) · Science · doi:10.1126/science.aao0505 · Cited by 459
Activity-based probes for the proteomic profiling of metalloproteases
Saghatelian, A., Jessani, N., Joseph, A., Humphrey, M., & Cravatt, B. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402784101 · Cited by 456
Rasmussen, H. S., & McCann, P. P. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00023-5 · Cited by 413
Cauwe, B., Van den Steen, P. E., & Opdenakker, G. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701340019 · Cited by 381
Hadler-Olsen, E., Winberg, J.-O., & Uhlin-Hansen, L. (2013) · Tumor Biology · doi:10.1007/s13277-013-0842-8 · Cited by 366
Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
Devy, L., Huang, L., Naa, L., Yanamandra, N., Pieters, H., Frans, N., Chang, E., Tao, Q., Vanhove, M., Lejeune, A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3255 · Cited by 355
Weisburger, J. H., & Weisburger, E. K. (1973) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06587-1 · Cited by 352
Chun, T.-H., Sabeh, F., Ota, I., Murphy, H., McDonagh, K. T., Holmbeck, K., Birkedal-Hansen, H., Allen, E. D., & Weiss, S. J. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200405001 · Cited by 349
Towards third generation matrix metalloproteinase inhibitors for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603043 · Cited by 340
Bernstein, K. E., Ong, F. S., Blackwell, W.-L. B., Shah, K. H., Giani, J. F., Gonzalez-Villalobos, R. A., Shen, X. Z., & Fuchs, S. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006809 · Cited by 324
Jacobsen, J. A., Major Jourden, J. L., Miller, M. T., & Cohen, S. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.08.006 · Cited by 313
Martignetti, J. A., Aqeel, A. A., Sewairi, W. A., Boumah, C. E., Kambouris, M., Mayouf, S. A., Sheth, K. V., Eid, W. A., Dowling, O., Harris, J., et al. (2001) · Nature Genetics · doi:10.1038/90100 · Cited by 312
Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3
Saunders, W. B., Bohnsack, B. L., Faske, J. B., Anthis, N. J., Bayless, K. J., Hirschi, K. K., & Davis, G. E. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200603176 · Cited by 296
Recent advances in matrix metalloproteinase inhibitor research
Beckett, R. P., Davidson, A. H., Drummond, A. H., Huxley, P., & Whittaker, M. (1996) · Drug Discovery Today · doi:10.1016/1359-6446(96)89115-x · Cited by 281
Increased inflammation delays wound healing in mice deficient in collagenase‐2 (MMP‐8)
Gutiérrez-Fernández, A., Inada, M., Balbín, M., Fueyo, A., Pitiot, A. S., Astudillo, A., Hirose, K., Hirata, M., Shapiro, S. D., Noël, A., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7860com · Cited by 281
MMPs as therapeutic targets—Still a viable option?
FINGLETON, B. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2007.06.006 · Cited by 279
Matrix Metalloproteinases as Therapeutic Targets in Cancer
Vihinen, P., Ala-aho, R., & Kahari, V.-M. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009053765799 · Cited by 277
Matrix metalloproteinases: roles in cancer and metastasis
Fingleton, B. (2006) · Frontiers in Bioscience · doi:10.2741/1811 · Cited by 271
Metalloproteases and inhibitors in arthritic diseases
Martel-Pelletier, J., Welsch, D. J., & Pelletier, J.-P. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0195 · Cited by 270
Matrix metalloproteinases as regulators of inflammatory processes
Fingleton, B. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.05.010 · Cited by 261
Gálvez, B. G., Matı́as-Román, S., Albar, J. P., Sánchez-Madrid, F., & Arroyo, A. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104094200 · Cited by 251
Matrix Metalloproteinases as Valid Clinical Target
Fingleton, B. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207779313551 · Cited by 246
Minocycline to Improve Neurologic Outcome in Stroke (MINOS): A Dose-Finding Study
Fagan, S. C., Waller, J. L., Nichols, F. T., Edwards, D. J., Pettigrew, L. C., Clark, W. M., Hall, C. E., Switzer, J. A., Ergul, A., & Hess, D. C. (2010) · Stroke · doi:10.1161/strokeaha.110.582601 · Cited by 244
Pruijt, J. F. M., Fibbe, W. E., Laterveer, L., Pieters, R. A., Lindley, I. J. D., Paemen, L., Masure, S., Willemze, R., & Opdenakker, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10863 · Cited by 228
Butler, G. S., & Overall, C. M. (2009) · Biochemistry · doi:10.1021/bi901656f · Cited by 224
Stratman, A. N., Saunders, W. B., Sacharidou, A., Koh, W., Fisher, K. E., Zawieja, D. C., Davis, M. J., & Davis, G. E. (2009) · Blood · doi:10.1182/blood-2008-12-196451 · Cited by 223
Jones, P. A., & DeClerck, Y. A. (1980) · PubMed · Cited by 218
Marshall, D. C., Lyman, S. K., McCauley, S., Kovalenko, M., Spangler, R., Liu, C., Lee, M., O’Sullivan, C., Barry-Hamilton, V., Ghermazien, H., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127063 · Cited by 201
PETERSON, J. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.11.032 · Cited by 196
Zou, K., Yamaguchi, H., Akatsu, H., Sakamoto, T., Ko, M., Mizoguchi, K., Gong, J.-S., Yu, W., Yamamoto, T., Kosaka, K., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1549-07.2007 · Cited by 187
Next generation matrix metalloproteinase inhibitors — Novel strategies bring new prospects
Levin, M., Udi, Y., Solomonov, I., & Sagi, I. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.06.009 · Cited by 186
Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis
Metz, L. M., Li, D. K. B., Traboulsee, A. L., Duquette, P., Eliasziw, M., Cerchiaro, G., Greenfield, J., Riddehough, A., Yeung, M., Kremenchutzky, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608889 · Cited by 184
Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke
Ning, M., Furie, K. L., Koroshetz, W. J., Lee, H., Barron, M., Lederer, M., Wang, X., Zhu, M., Sorensen, A. G., Lo, E. H., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000216133.98416.b4 · Cited by 182
Acceleration of diabetic wound healing using a novel protease–anti-protease combination therapy
Gao, M., Nguyen, T. T., Suckow, M. A., Wolter, W. R., Gooyit, M., Mobashery, S., & Chang, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517847112 · Cited by 182
Baragi, V. M., Becher, G., Bendele, A. M., Biesinger, R., Bluhm, H., Boer, J., Deng, H., Dodd, R., Essers, M., Feuerstein, T., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24629 · Cited by 174
Minocycline reduces gadolinium‐enhancing magnetic resonance imaging lesions in multiple sclerosis
Metz, L. M., Zhang, Y., Yeung, M., Patry, D. G., Bell, R. B., Stoian, C. A., Yong, V. W., Patten, S. B., Duquette, P., Antel, J. P., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20111 · Cited by 171
Dezube, B. J., Krown, S. E., Lee, J. Y., Bauer, K. S., & Aboulafia, D. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2614 · Cited by 168
Bloomston, M., Zervos, E. E., & Rosemurgy, A. S. (2002) · Annals of Surgical Oncology · doi:10.1007/bf02574483 · Cited by 165
Passenger Mutations Confound Interpretation of All Genetically Modified Congenic Mice
Vanden Berghe, T., Hulpiau, P., Martens, L., Vandenbroucke, R. E., Van Wonterghem, E., Perry, S. W., Bruggeman, I., Divert, T., Choi, S. M., Vuylsteke, M., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.011 · Cited by 164
Development of Selective Inhibitors and Substrate of Matrix Metalloproteinase-12
Devel, L., Rogakos, V., David, A., Makaritis, A., Beau, F., Cuniasse, P., Yiotakis, A., & Dive, V. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600222200 · Cited by 160
Sela-Passwell, N., Rosenblum, G., Shoham, T., & Sagi, I. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.04.010 · Cited by 160
Scannevin, R. H., Alexander, R., Haarlander, T. M., Burke, S. L., Singer, M., Huo, C., Zhang, Y.-M., Maguire, D., Spurlino, J., Deckman, I., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.806075 · Cited by 160
Matrix metalloproteases: Underutilized targets for drug delivery
Vartak, D. G., & Gemeinhart, R. A. (2007) · Journal of drug targeting · doi:10.1080/10611860600968967 · Cited by 159
Sela-Passwell, N., Kikkeri, R. V., Dym, O., Rozenberg, H., Margalit, R., Arad‐Yellin, R., Eisenstein, M., Brenner, O. J., Shoham, T., Danon, T., et al. (2011) · Nature Medicine · doi:10.1038/nm.2582 · Cited by 158
Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer
Radisky, E. S., Raeeszadeh‐Sarmazdeh, M., & Radisky, D. C. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26185 · Cited by 155
Ansari, C., Tikhomirov, G. A., Hong, S. H., Falconer, R. A., Loadman, P. M., Gill, J. H., Castaneda, R., Hazard, F. K., Tong, L., Lenkov, O. D., et al. (2013) · Small · doi:10.1002/smll.201301456 · Cited by 154
Nguyen, T. T., Ding, D., Wolter, W. R., Pérez, R. L., Champion, M. M., Mahasenan, K. V., Hesek, D., Lee, M., Schroeder, V. A., Jones, J. I., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01005 · Cited by 149
Remacle, A. G., Golubkov, V. S., Shiryaev, S. A., Dahl, R. S., Stebbins, J. L., Chernov, A. V., Cheltsov, A. V., Pellecchia, M., & Strongin, A. Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4149 · Cited by 146
Tochowicz, A., Maskos, K., Huber, R., Oltenfreiter, R., Dive, V., Yiotakis, A., Zanda, M., Bode, W., & Goettig, P. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.068 · Cited by 145
Vandenbroucke, R. E., Dejonckheere, E., Hauwermeiren, F. V., Lodens, S., Rycke, R. M. D., Wonterghem, E. V., Staes, A., Gevaert, K., López-Otín, C., & Libert, C. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202100 · Cited by 143
Zinc‐Binding Groups Modulate Selective Inhibition of MMPs
Agrawal, A., Romero‐Perez, D., Jacobsen, J. A., Villarreal, F. J., & Cohen, S. M. (2008) · ChemMedChem · doi:10.1002/cmdc.200700290 · Cited by 143
Switzer, J. A., Hess, D. C., Ergul, A., Waller, J. L., Machado, L. S., Portik‐Dobos, V., Pettigrew, L. C., Clark, W. M., & Fagan, S. C. (2011) · Stroke · doi:10.1161/strokeaha.111.618215 · Cited by 142
MT1-MMP: Universal or particular player in angiogenesis?
Genı́s, L., Gálvez, B. G., Gonzalo, P., & Arroyo, A. G. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7891-z · Cited by 141
Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases
Fields, G. B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01278 · Cited by 140
Self-citationAger, E. I., Kozin, S. V., Kirkpatrick, N. D., Seano, G., Kodack, D. P., Askoxylakis, V., Huang, Y., Goel, S., Snuderl, M., Muzikansky, A., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv017 · Cited by 138
Sacharidou, A., Koh, W., Stratman, A. N., Mayo, A. M., Fisher, K. E., & Davis, G. E. (2010) · Blood · doi:10.1182/blood-2009-11-252692 · Cited by 134
Matrix metalloproteinase inhibitors 1998
Beckett, R. P., & Whittaker, M. A. (1998) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.8.3.259 · Cited by 133
Liu, G., Atteridge, C. L., Wang, X., Lundgren, A. D., & Wu, J. D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903789 · Cited by 131
Molecular Targets in Osteoarthritis: Metalloproteinases and Their Inhibitors
Burrage, P., & Brinckerhoff, C. (2007) · Current Drug Targets · doi:10.2174/138945007779940098 · Cited by 128
Kim, H., Chung, H., Kim, J., Choi, D., Shin, Y., Kang, Y. G., Kim, B., Seo, S., Chung, S. H., & Seok, S. H. (2019) · Advanced Science · doi:10.1002/advs.201900195 · Cited by 123
Vandenbroucke, R. E., Dejonckheere, E., Lint, P. V., Demeestere, D., Wonterghem, E. V., Vanlaere, I., Puimège, L., Hauwermeiren, F. V., Rycke, R. M. D., Guire, C. M., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0967-12.2012 · Cited by 122
Cuniasse, P., Devel, L., Makaritis, A., Beau, F., Georgiadis, D., Matziari, M., Yiotakis, A., & Dive, V. (2004) · Biochimie · doi:10.1016/j.biochi.2004.09.025 · Cited by 117
Vassiliou, S., Mucha, A., Cuniasse, P., Georgiadis, D., Lucet-Levannier, K., Beau, F., Kannan, R., Murphy, G., Knäuper, V., Rio, M., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9900164 · Cited by 114
Proteases in cancer drug delivery
Vandooren, J., Opdenakker, G., Loadman, P. M., & Edwards, D. R. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.020 · Cited by 114
Targeting MMP-9 in Diabetic Foot Ulcers
Jones, J. I., Nguyen, T. T., Peng, Z., & Chang, M. (2019) · Pharmaceuticals · doi:10.3390/ph12020079 · Cited by 114
Preshaw, P. M., Hefti, A. F., Novak, M. J., Michalowicz, B. S., Pihlstrom, B. L., Schoor, R., Trummel, C. L., Dean, J. W., Dyke, T. E. V., Walker, C., et al. (2004) · Journal of Periodontology · doi:10.1902/jop.2004.75.8.1068 · Cited by 112
Juric, V., O’Sullivan, C., Stefanutti, E., Kovalenko, M. A., Greenstein, A. E., Barry-Hamilton, V., Mikaelian, I., Degenhardt, J. D., Peng, Y., Smith, V., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207255 · Cited by 110
Lauhio, A., Hästbacka, J., Pettilä, V., Tervahartiala, T. I., Karlsson, S., Varpula, T., Varpula, M., Ruokonen, E., Sorsa, T. A., & Kolho, E. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.06.019 · Cited by 107
Hydroxamates: Relationships between Structure and Plasma Stability
Flipo, M., Charton, J., Hocine, A., Dassonneville, S., Deprez, B. P., & Deprez-Poulain, R. F. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900648x · Cited by 105
Huang, W., Meng, Q., Suzuki, K., Nagase, H., & Brew, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22086 · Cited by 105
Edwards, D. R., Høyer‐Hansen, G., Blasi, F., & Sloane, B. F. (2008) · Springer eBooks · doi:10.1007/978-0-387-69057-5 · Cited by 104
Gall, A.-L., Ruff, M., Kannan, R., Cuniasse, P., Yiotakis, A., Dive, V., Rio, M., Basset, P., & Moras, D. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4493 · Cited by 103
Metz, L., Li, D. K. B., Traboulsee, A. L., Myles, M. L., Duquette, P., Godin, J., Constantin, M., & Yong, V. W. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509106779 · Cited by 102
Becker, D. P., Barta, T. E., Bedell, L. J., Boehm, T. L., Bond, B. R., Carroll, J. N., Carron, C. P., DeCrescenzo, G. A., Easton, A. M., Freskos, J. N., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100669j · Cited by 101
Pro-inflammatory effects of matrix metalloproteinase 7 in acute inflammation
Vandenbroucke, R. E., Vanlaere, I., Hauwermeiren, F. V., Wonterghem, E. V., Wilson, C. L., & Libert, C. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.76 · Cited by 101
Appleby, T. C., Greenstein, A. E., Hung, M., Liclican, A. C., Velasquez, M., Villaseñor, A. G., Wang, R., Wong, M. H. L., Liu, X., Papalia, G. A., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.760579 · Cited by 101
A novel role for matrix metalloproteinase-8 in sepsis*
Solan, P. D., Dunsmore, K. E., Denenberg, A. G., Odoms, K., Zingarelli, B., & Wong, H. R. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318232e404 · Cited by 97
Shah, M. A., Starodub, A., Sharma, S., Berlin, J. D., Patel, M., Wainberg, Z. A., Chaves, J. M., Gordon, M. S., Windsor, K. S., Brachmann, C. B., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2469 · Cited by 97
Hepatic Disposition of Electrophilic Acyl Glucuronide Conjugates
Sallustio, B. C., Sabordo, L., Evans, A. M., & Nation, R. L. (2000) · Current Drug Metabolism · doi:10.2174/1389200003339153 · Cited by 96
Epidermal Development and Wound Healing in Matrix Metalloproteinase 13-Deficient Mice
Hartenstein, B., Dittrich, B. T., Stickens, D., Heyer, B. S., Vu, T. H., Teurich, S., Schorpp‐Kistner, M., Werb, Z., & Angel, P. E. (2005) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700084 · Cited by 94
Talmi-Frank, D., Altboum, Z., Solomonov, I., Udi, Y., Jaitin, D. A., Klepfish, M., David, E., Zhuravlev, A., Keren‐Shaul, H., Winter, D. R., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.09.005 · Cited by 94
Ling, B., Watt, K., Banerjee, S., Newsted, D., Truesdell, P., Adams, J., Sidhu, S. S., & Craig, A. W. B. (2017) · Oncotarget · doi:10.18632/oncotarget.17702 · Cited by 92
Paemen, L. R., Martens, E., Masure, S., & Opdenakker, G. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.759_a.x · Cited by 92
Matrix metalloproteinases and inhibitors in dentistry
Boelen, G., Boute, L., d’Hoop, J., EzEldeen, M., Lambrichts, I., & Opdenakker, G. (2019) · Clinical Oral Investigations · doi:10.1007/s00784-019-02915-y · Cited by 92
Sanderson, L., Taylor, G. W., Aboagye, E. O., Alao, J. P., Latigo, J. R., Coombes, R. C., & Vigushin, D. M. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000638 · Cited by 90
Lauer‐Fields, J. L., Chalmers, M. J., Busby, S. A., Minond, D., Griffin, P. R., & Fields, G. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016873 · Cited by 88
Self-citationCao, J. P., Kozarekar, P., Pavlaki, M., Chiarelli, C., Bahou, W. F., & Zucker, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312120200 · Cited by 86
Selective Modulation of Matrix Metalloproteinase 9 (MMP-9) Functions via Exosite Inhibition
Lauer‐Fields, J. L., Whitehead, J. K., Li, S., Hammer, R. P., Brew, K., & Fields, G. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801438200 · Cited by 85
Self-citationSelective Matrix Metalloproteinase Inhibitors for Cancer
Li, N., Shi, Z., Tang, Y., & Duan, J. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789178037 · Cited by 85
Minagar, A., Alexander, J. S., Schwendimann, R. N., Kelley, R. E., Gonzalez‐Toledo, E., Jimenez, J. J., Mauro, L., Jy, W., & Smith, S. J. (2007) · Archives of Neurology · doi:10.1001/archneurol.2007.41 · Cited by 84
Active-site MMP-selective antibody inhibitors discovered from convex paratope synthetic libraries
Nam, D. H., Rodríguez, C., Remacle, A. G., Strongin, A. Y., & Ge, X. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609375114 · Cited by 83
MT-MMPS as Regulators of Vessel Stability Associated with Angiogenesis
Sounni, N. E., Paye, A., Host, L., & Noël, A. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00111 · Cited by 82
Pochetti, G., GAVUZZO, E., Campestre, C., Agamennone, M., Tortorella, P., Consalvi, V., Gallina, C., Hiller, O., Tschesche, H., Tucker, P. A., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050787+ · Cited by 80
Meng, Q., Malinovskii, V. A., Huang, W., Hu, Y., Chung, L., Nagase, H., Bode, W., Maskos, K., & Brew, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10184 · Cited by 80
Devy, L., & Dransfield, D. T. (2010) · Biochemistry Research International · doi:10.1155/2011/191670 · Cited by 78
Hamze, A. B., Wei, S., Bahudhanapati, H., Kota, S., Acharya, K. R., & Brew, K. (2007) · Protein Science · doi:10.1110/ps.072978507 · Cited by 78
Arkadash, V., Yosef, G., Shirian, J., Cohen, I., Horev, Y., Grossman, M., Sagi, I., Radisky, E. S., Shifman, J. M., & Papo, N. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.756718 · Cited by 77
Clinical Trials of a Matrix Metalloproteinase Inhibitor in Human Periodontal Disease
Ashley, R. A. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07693.x · Cited by 76
Mulder, G. J., & Meerman, J. H. (1983) · Environmental Health Perspectives · doi:10.1289/ehp.834927 · Cited by 76
Lee, M., Rapti, M., & Murphy, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305678200 · Cited by 73
New approaches to selectively target cancer-associated matrix metalloproteinase activity
Tauro, M., McGuire, J., & Lynch, C. C. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9530-4 · Cited by 70 · cited 1×
“Overall, the previous poor performance of MMP inhibitors in clinical trials has been attributed to (a) inhibition of other metalloenzymes, (b) lack of specificity within the MMP family, (c) poor pharmacokinetics, (d) dose-limiting side effects/toxicity, (e) in vivo instability, and (f) low oral availability/inability…”
BackgroundMMPs and ADAMs in neurological infectious diseases and multiple sclerosis
Muri, L., Leppert, D., Grandgirard, D., & Leib, S. L. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03174-6 · Cited by 70
A Bioinorganic Perspective on Matrix Metalloproteinase Inhibition
Puerta, D. T., & Cohen, S. M. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387368 · Cited by 68
Woskowicz, A., Weaver, S. A., Shitomi, Y., Ito, N., & Itoh, Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.496067 · Cited by 68
Lauer‐Fields, J. L., Brew, K., Whitehead, J. K., Li, S., Hammer, R. P., & Fields, G. B. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0715849 · Cited by 67
Self-citationMatrix metalloproteinases and ADAMs in stroke
Montaner, J., Ramiro, L., Simats, A., Hernández‐Guillamón, M., Delgado, P., Bustamante, A., & Rosell, A. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03175-5 · Cited by 67
Batra, J., Robinson, J., Mehner, C., Hockla, A., Miller, E. E., Radisky, D. C., & Radisky, E. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050028 · Cited by 66
Iyer, R. P., Brás, L. E. D. C., Patterson, N. L., Bhowmick, M., Flynn, E. R., Asher, M., Cannon, P. L., DeLeon‐Pennell, K. Y., Fields, G. B., & Lindsey, M. L. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.10.005 · Cited by 66
Self-citationXie, X., Wan, R., & Liu, Z. (2017) · ChemMedChem · doi:10.1002/cmdc.201700349 · Cited by 66
Makaritis, A., Georgiadis, D., Dive, V., & Yiotakis, A. (2003) · Chemistry - A European Journal · doi:10.1002/chem.200204456 · Cited by 65
Matrix Metalloproteinase Inhibitors: Do They Have a Place in Anticancer Therapy?
Rudek, M. A., Venitz, J., & Figg, W. D. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.9.705.34062 · Cited by 62
Matrix Metalloprotease-1a Promotes Tumorigenesis and Metastasis
Foley, C. J., Luo, C., O’Callaghan, K., Hinds, P. W., Covic, L., & Kuliopulos, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356303 · Cited by 62
Sandborn, W. J., Bhandari, B. R., Fogel, R., Onken, J. E., Yen, E., Zhao, X., Jiang, Z., Ge, D., Xin, Y., Ye, Z., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13653 · Cited by 62
Controlling Plasma Stability of Hydroxamic Acids: A MedChem Toolbox
Hermant, P., Bosc, D., Piveteau, C., Gealageas, R., Lam, B., Ronco, C., Roignant, M., Tolojanahary, H., Jean, L., Renard, P., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01444 · Cited by 62
Grünwald, B. T., Vandooren, J., Gerg, M., Ahomaa, K., Hunger, A., Berchtold, S., Akbareian, S. E., Schaten, S., Knolle, P. A., Edwards, D. R., et al. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0180 · Cited by 61
Lauer‐Fields, J. L., Minond, D., Chase, P. S., Baillargeon, P., Saldanha, S. A., Stawikowska, R., Hodder, P., & Fields, G. B. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.03.004 · Cited by 60
Self-citationInhibition Mechanism of Membrane Metalloprotease by an Exosite-Swiveling Conformational Antibody
Udi, Y., Grossman, M., Solomonov, I., Dym, O., Rozenberg, H., Moreno, V., Cuniasse, P., Dive, V., Arroyo, A. G., & Sagi, I. (2014) · Structure · doi:10.1016/j.str.2014.10.012 · Cited by 60
Targeting a Single Function of the Multifunctional Matrix Metalloprotease MT1-MMP
Ingvarsen, S., Porse, A., Erpicum, C., Maertens, L., Jürgensen, H. J., Madsen, D. H., Melander, M. C., Gårdsvoll, H., Høyer‐Hansen, G., Noël, A., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.447169 · Cited by 60
Buchardt, J., Schiødt, C. B., Krog-Jensen, C., Delaissé, J., Foged, N. T., & Meldal, M. (2000) · Journal of Combinatorial Chemistry · doi:10.1021/cc000031q · Cited by 59
Liu, S., Ando, F., Fujita, Y., Liu, J., Maeda, T., Shen, X., Kikuchi, K., Matsumoto, A., Yokomori, M., Tanabe, C., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006420 · Cited by 59
Tumour endoproteases: the cutting edge of cancer drug delivery?
Atkinson, J. M., Siller, C. S., & Gill, J. H. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707657 · Cited by 58
Protein Engineering of the Tissue Inhibitor of Metalloproteinase 1 (TIMP-1) Inhibitory Domain
Wei, S., Chen, Y., Chung, L., Nagase, H., & Brew, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211793200 · Cited by 58
Koike, T., Vernon, R. B., Hamner, M. A., Sadoun, E., & Reed, M. J. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10257 · Cited by 58
de Bruyn, M., Breynaert, C. M., Arijs, I., Hertogh, G. D., Geboes, K., Thijs, G., Matteoli, G., Hu, J., Damme, J. V., Arnold, B., et al. (2017) · Nature Communications · doi:10.1038/ncomms15384 · Cited by 58
Matrix metalloproteinases in the CNS: interferons get nervous
Chopra, S., Overall, C. M., & Dufour, A. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03171-9 · Cited by 56
Suojanen, J., Salo, T. A., Koivunen, E., Sorsa, T. A., & Pirilä, E. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.24.10139 · Cited by 55
Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors
Choi, J. Y., Fuerst, R., Knapinska, A. M., Taylor, A. B., Smith, L., Cao, X., Hart, P. J., Fields, G., & Roush, W. R. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00514 · Cited by 53
Self-citationNara, H., Sato, K., Naito, T., Mototani, H., Oki, H., Yamamoto, Y., Kuno, H., Santou, T., Kanzaki, N., Terauchi, J., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.07.025 · Cited by 52
Sandborn, W. J., Bhandari, B. R., Randall, C. W., Younes, Z. H., Romańczyk, T., Xin, Y., Wendt, E., Chai, H., McKevitt, M., Zhao, S., et al. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy049 · Cited by 51
Raeeszadeh‐Sarmazdeh, M., Greene, K., Sankaran, B., Downey, G. P., Radisky, D. C., & Radisky, E. S. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008321 · Cited by 50
Production of multivalent protein binders using a self‐trimerizing collagen‐like peptide scaffold
Fan, C., Huang, C., Chiu, W., Lai, C., Liou, G., Li, H., & Chou, M. (2008) · The FASEB Journal · doi:10.1096/fj.08-111484 · Cited by 48
Alford, V. M., Kamath, A., Ren, X., Kumar, K., Gan, Q., Awwa, M., Tong, M., Seeliger, M. A., Cao, J. P., Ojima, I., et al. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00758 · Cited by 48
Phage Display of Tissue Inhibitor of Metalloproteinases-2 (TIMP-2)
Bahudhanapati, H., Zhang, Y., Sidhu, S. S., & Brew, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.253328 · Cited by 47
A Novel Theranostic Strategy for MMP-14 –Expressing Glioblastomas Impacts Survival
Mohanty, S., Chen, Z., Li, K., Morais, G. R., Klockow, J., Yerneni, K., Pisani, L. J., Chin, F. T., Mitra, S., Cheshier, S. H., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0022 · Cited by 47
Yosef, G., Arkadash, V., & Papo, N. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004406 · Cited by 47
Sharabi, O., Shirian, J., Grossman, M., Lebendiker, M., Sagi, I., & Shifman, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093712 · Cited by 46
Remacle, A. G., Cieplak, P., Nam, D. H., Shiryaev, S. A., Ge, X., & Strongin, A. Y. (2016) · Oncotarget · doi:10.18632/oncotarget.13157 · Cited by 45
Buchardt, J., Ferreras, M., Krog-Jensen, C., Delaissé, J., Foged, N. T., & Meldal, M. (1999) · Chemistry - A European Journal · Cited by 44
Brás, L. E. D. C., Cates, C. A., DeLeon‐Pennell, K. Y., et al. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5411 · Cited by 43
Monoclonal antibodies against metzincin targets
Santamaria, S., & de Groot, R. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14186 · Cited by 43
Breuer, E., Salomon, C. J., Katz, Y., Chen, W., Lu, S., Röschenthaler, G., Hadar, R., & Reich, R. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030386z · Cited by 42
Basu, B., de Sampaio, P. C., Mohammed, H., Fogarasi, M., Corrie, P. G., Watkins, N. A., Smethurst, P. A., English, W., Ouwehand, W. H., & Murphy, G. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.11.015 · Cited by 42
Hoffman, A., Qadri, B., Frant, J., Katz, Y., Bhusare, S. R., Breuer, E., Hadar, R., & Reich, R. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701087n · Cited by 41
Bøtkjær, K. A., Kwok, H. F., Terp, M. G., Karatt-Vellatt, A., Santamaria, S., McCafferty, J., Andreasen, P. A., Itoh, Y., Ditzel, H. J., & Murphy, G. (2016) · Oncotarget · doi:10.18632/oncotarget.7780 · Cited by 41
Butler, G. S., & Overall, C. M. (2006) · Current Pharmaceutical Design · doi:10.2174/138161207779313524 · Cited by 39
Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket
Reiter, L. A., Rizzi, J. P., Pandit, J., Lasut, M. J., McGahee, S. M., Parikh, V. D., Blake, J. F., Danley, D. E., Laird, E. R., Lopez‐Anaya, A., et al. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00729-x · Cited by 36
Bianchini, G., Aschi, M., Cavicchio, G., Crucianelli, M., Preziuso, S., Gallina, C., Nastari, A., GAVUZZO, E., & Mazza, F. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.079 · Cited by 36
Spicer, T., Jiang, J., Taylor, A. B., Choi, J. Y., Hart, P. J., Roush, W. R., Fields, G. B., Hodder, P., & Minond, D. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501284e · Cited by 35
Self-citationIdentification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds
Roth, J., Minond, D., Darout, E., Liu, Q., Lauer, J. L., Hodder, P., Fields, G. B., & Roush, W. R. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.09.077 · Cited by 35
Self-citationRuminski, P., Massa, M. A., Strohbach, J. W., Hanau, C. E., Schmidt, M. A., Scholten, J. A., Fletcher, T., Hamper, B. C., Carroll, J. N., Shieh, H. S., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01434 · Cited by 35
Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3
Reiter, L. A., Mitchell, P. G., Martinelli, G. J., Lopresti‐Morrow, L., Yocum, S. A., & Eskra, J. D. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00413-x · Cited by 34
Winer, A., Janosky, M. D., Harrison, B. T., Zhong, J., Moussai, D., Si̇yah, P., Schatz-Siemers, N., Zeng, J. J., Adams, S., & Mignatti, P. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0194 · Cited by 34
Gill, J. H., Loadman, P. M., Shnyder, S. D., et al. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400760b · Cited by 33
Sela-Passwell, N., Trahtenherts, A., Krüger, A., & Sagi, I. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.560936 · Cited by 33
Peptide internalization enabled by folding: triple helical cell-penetrating peptides
Shinde, A. B., Feher, K. M., Hu, C., & Slowinska, K. (2014) · Journal of Peptide Science · doi:10.1002/psc.2725 · Cited by 31
Second Generation Triple-Helical Peptide Inhibitors of Matrix Metalloproteinases
Bhowmick, M., Tokmina‐Roszyk, D., Onwuha-Ekpete, L. C., Harmon, K., Robichaud, T. K., Fuerst, R., Stawikowska, R., Steffensen, B., Roush, W. R., Wong, H. R., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00018 · Cited by 31
Self-citationNdinguri, M. W., Zheleznyak, A., Lauer, J. L., Anderson, C. J., & Fields, G. B. (2012) · Journal of Drug Delivery · doi:10.1155/2012/592602 · Cited by 27
Self-citationRiding the metalloproteinase roller coaster
Murphy, G. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.x117.785295 · Cited by 25
Clinical Implications of Compounds Designed to Inhibit ECM‐Modifying Metalloproteinases
Amar, S., Minond, D., & Fields, G. B. (2017) · PROTEOMICS · doi:10.1002/pmic.201600389 · Cited by 25
Self-citationIntestine-Derived Matrix Metalloproteinase-8 Is a Critical Mediator of Polymicrobial Peritonitis*
Atkinson, S. J., Nolan, M. C., Klingbeil, L. R., Harmon, K., Lahni, P. M., Zingarelli, B., & Wong, H. R. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001374 · Cited by 24
Angiotensin-converting enzyme defines matrikine-regulated inflammation and fibrosis
O’Reilly, P. J., Ding, Q., Akthar, S., Cai, G., Genschmer, K. R., Patel, D. F., Jackson, P. L., Viera, L., Roda, M. A., Locy, M. L., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.91923 · Cited by 23
Arkadash, V., Radisky, E. S., & Papo, N. (2018) · Oncotarget · doi:10.18632/oncotarget.25885 · Cited by 23
Yasui, H., Yamazaki, C. M., Nose, H., Awada, C., Takao, T., & Koide, T. (2013) · Biopolymers · doi:10.1002/bip.22234 · Cited by 22
Bhowmick, M., Stawikowska, R., Tokmina‐Roszyk, D., & Fields, G. (2015) · ChemBioChem · doi:10.1002/cbic.201402716 · Cited by 21
Self-citationA Sensitive Assay for Collagenolytic Activity Using Tritiated Collagen
Labrosse, K. R., Liener, I. E., & Hargrave, P. A. (1976) · Analytical Biochemistry · doi:10.1016/s0378-5173(83)90103-5 · Cited by 20
Fuerst, R., Choi, J. Y., Knapinska, A. M., Smith, L., Cameron, M. D., Ruiz, C. H., Fields, G., & Roush, W. R. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.08.020 · Cited by 19
Self-citationKitamura, S., Sugihara, K., & Tatsumi, K. (1994) · PubMed · Cited by 18
Steeland, S., Ryckeghem, S. V., Vandewalle, J., Ballegeer, M., Wonterghem, E. V., Eggermont, M., Decruyenaere, J. M. A., Bus, L. D., Libert, C., & Vandenbroucke, R. E. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002813 · Cited by 17
Jiang, B., Liu, J., & Lee, M. H. (2019) · Molecules · doi:10.3390/molecules24020255 · Cited by 16
Duan, J., Rapti, M., Tsigkou, A., & Lee, M. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136384 · Cited by 15
Frant, J., Veerendhar, A., Chernilovsky, T., Nedvetzki, S., Vaksman, O., Hoffman, A., Breuer, E., & Reich, R. (2011) · ChemMedChem · doi:10.1002/cmdc.201100153 · Cited by 12
Song, D., Lee, C., Kook, Y. J., Oh, S. J., Kang, J. S., Kim, H. J., & Han, G. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.11.055 · Cited by 8
Rationalized Computer-Aided Design of Matrix-Metalloprotease-Selective Prodrugs
Jain, M., Harburn, J. J., Gill, J. H., Loadman, P. M., Falconer, R. A., Mooney, C. A., Cobb, S. L., & Berry, D. J. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01472 · Cited by 7
Rethinking Brain Cancer Therapy: Tumor Enzyme Activatable Theranostic Nanoparticles
Daldrup-Link, H. E. (2017) · Molecular Imaging · doi:10.1177/1536012117730950 · Cited by 7
Cited by
de Almeida, L. G. N., Thode, H., Eslambolchi, Y., Chopra, S., Young, D., Gill, S., Devel, L., & Dufour, A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000349 · Cited by 535
Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression
Niland, S., Riscanevo, A. X., & Eble, J. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010146 · Cited by 503
Tumor microenvironment: barrier or opportunity towards effective cancer therapy
Tiwari, A., Trivedi, R., & Lin, S.-Y. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00866-3 · Cited by 377
Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics
Raeeszadeh-Sarmazdeh, M., Do, L., & Hritz, B. (2020) · Cells · doi:10.3390/cells9051313 · Cited by 324
Mechanisms of assembly and remodelling of the extracellular matrix
Naba, A. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00767-3 · Cited by 316
Metadata
- Authors
- Fields, G. B.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-08-27
- Volume
- 8
- Issue
- 9
- Pages
- 984
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W2970104014
- Cited by
- 299
- References
- 198
- FWCI
- 11.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.